The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study

The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study

Abstract Purpose Some studies have indicated that using 500 mg/m2 rituximab combined with CHOP‐14 may be beneficial for elderly men but not women with diffuse large B‐cell lymphoma (DLBCL). The purpose of this study was to investigate the potential benefit of escalated doses of rituximab with CHOP‐2...

Full description

Bibliographic Details
Main Authors: Hai‐Xia He, Yan Gao, Bing Bai, Xiao‐Xiao Wang, Ji‐Bin Li, Cheng Huang, Jia‐Ying Mao, Li‐Qin Ping, Qi‐Xiang Rong, Yan‐Xia He, He Huang, Qing‐Qing Cai, Zhi‐Ming Li, Wen‐Qi Jiang, Hui‐Qiang Huang
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Cancer Medicine
Subjects:
diffuse large B‐cell lymphoma
elderly males
escalated
R‐CHOP
rituximab
standard
Online Access:https://doi.org/10.1002/cam4.4296

Internet

https://doi.org/10.1002/cam4.4296

Similar Items